Pharmacological Conditions
Pharmacological Conditions - Related Videos
10:36
Behavioural Pharmacology in Classical Conditioning of the Proboscis Extension Response in Honeybees (Apis mellifera)
0 Views •
Cited by 50 •
2011
We demonstrate how to implement a behavioral pharmacology method in an appetitive olfactory conditioning paradigm in honeybees (Apis mellifera) by systemic application of drugs. This method allows investigation of the mechanisms underlying learning and memory formation in a simple and reliable way.
08:49
Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
0 Views •
Cited by 23 •
2013
Loss of the righting reflex has long served as a standard behavioral surrogate for unconsciousness, also called hypnosis, in laboratory animals. Alterations in volatile anesthetic sensitivity caused by pharmacological interventions can be detected with a carefully controlled high-throughput assessment system, which may be adapted for delivery of any inhaled therapeutic.
09:58
Pharmacological and Functional Genetic Assays to Manipulate Regeneration of the Planarian Dugesia japonica
0 Views •
Cited by 17 •
2011
An attractive model for studying stem cell differentiation within a live animal is the planarian flatworm. Regeneration is studied by simple amputation experiments that are easily performed in a basic laboratory and are amenable to pharmacological and genetic (in vivo RNAi) manipulation as detailed by protocols in this article.
12:37
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
0 Views •
Cited by 13 •
2013
Epidermal melanin is induced by topical application of forskolin in a murine model of the fair-skinned UV-sensitive human. Pharmacologic manipulation of cAMP levels in the skin and epidermal darkening strongly protect against UV-mediated inflammation (sunburn) as measured by the minimum erythematous dose (MED) assay.
06:46
Fear Conditioning
0 Views •
2023
Fear Conditioning is a type of learning in which an association is established between a negative unpleasant event and a harmless stimulus. This leads to a fear of the harmless stimulus. This process is largely mediated by the amygdala, which is a brain region involved in emotions and stress reactions. Fear conditioning can be utilized in several ways to understand different aspects of learning and memory. This video presents an overview of the principles behind fear conditioning, discusses the...
FAQs
Concentration and exposure time determine how strongly and how long a compound can influence a neural system. Varying these parameters supports dose-response analysis, while keeping exposure consistent helps separate concentration-dependent effects from timing effects. This distinction is important when interpreting changes in neuronal activity, synaptic transmission, or behavior.
A control treatment provides the comparison needed to judge whether an observed neural or behavioral change follows from the compound rather than the experimental context. Matching relevant conditions, such as exposure and delivery, strengthens causal interpretation. Without that comparison, researchers may have difficulty distinguishing a pharmacological effect from variation introduced by the procedure itself.
These compounds probe neural mechanisms in different ways: agonists activate targeted receptors or pathways, antagonists block them, and inhibitors suppress specific molecular processes. Comparing the resulting effects can help identify whether a receptor, ion channel, transporter, or signaling pathway contributes to neuronal or synaptic changes. Such comparisons also aid evaluation of therapeutic targets.
Researchers match compound-related parameters across comparison groups, including identity, concentration, exposure time, delivery method, and control treatment. Consistency reduces avoidable differences and makes changes in neuronal activity, synaptic transmission, or behavior easier to attribute to the intended experimental contrast. This matching is central to distinguishing molecular mechanisms and interpreting drug effects.
Changes in neuronal activity, synaptic transmission, and behavior provide different kinds of evidence about drug action. Examining these outcomes under defined conditions helps connect molecular targets with neural function and behavior. That multilevel perspective is useful when testing how neural circuits contribute to disease or cognition.
Controlled drug-related conditions allow researchers to test whether altering receptors, ion channels, transporters, or signaling pathways changes neural function. Results from cellular, animal, and human research can reveal effects on neuronal activity, synaptic transmission, or behavior. This evidence supports evaluation of potential therapeutic targets and helps relate molecular mechanisms to disease or cognition.